KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) EBITDA Margin (2016 - 2022)

National Health Investors (NHI) has disclosed EBITDA Margin for 13 consecutive years, with 55.13% as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, EBITDA Margin rose 69.0% year-over-year to 55.13%, compared with a TTM value of 91.81% through Mar 2022, up 3198.0%, and an annual FY2021 reading of 2.76%, down 840.0% over the prior year.
  • EBITDA Margin was 55.13% for Q2 2021 at National Health Investors, up from 45.94% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 78.93% in Q3 2018 and bottomed at 45.62% in Q1 2019.
  • Average EBITDA Margin over 5 years is 62.12%, with a median of 55.47% recorded in 2018.
  • The sharpest move saw EBITDA Margin soared 2445bps in 2017, then tumbled -2588bps in 2018.
  • Year by year, EBITDA Margin stood at 78.65% in 2017, then grew by 0bps to 78.93% in 2018, then dropped by -3bps to 76.46% in 2019, then dropped by -29bps to 54.44% in 2020, then increased by 1bps to 55.13% in 2021.
  • Business Quant data shows EBITDA Margin for NHI at 55.13% in Q2 2021, 45.94% in Q1 2021, and 54.44% in Q2 2020.